OHSU Doernbecher patient first human to receive trial therapy for rare, devastating form of epilepsy

Multi-site phase 1/2a clinical study works to assess safety, dosage of promising drug to treat Dravet syndrome

By Tracy Brawley September 09, 2020 Portland, Oregon